Dr Christopher Hollowood
Dr Christopher Hollowood was appointed in a total of 8 companies and resigned from 8 of these appointments.
Roles
Director • Non-designated LLP Member
Country Of Residence
England
Nationality
British
Date of Birth
December 1974
Occupations
Company Director • Unreported • Investor
Active
0
Resigned
8
Dissolved
0
Other
0
Total
8
Companies
| Company | Timeline | Status | |
| Freeline Therapeutics Holdings Limited Director • Company Director | 26 Jun 2020←3 Years→15 Apr 2024 | Active | |
| Spur Therapeutics Limited Director • Director | 19 May 2015←5 Years→18 Feb 2021 | Active | |
| Nightstarx Limited Director • Director | 15 Nov 2013←3 Years→30 Oct 2017 | Active | |
Syncona Management LLP Non-designated LLP Member • Unreported | 16 Oct 2012←4 Years→20 Dec 2016 | Dissolved | |
Syncona Partners LLP Non-designated LLP Member • Unreported | 16 Oct 2012←4 Years→19 Dec 2016 | Dissolved | |
| Convergence Pharmaceuticals Holdings Limited Director • Investor | 26 Oct 2011←10 Months→31 Aug 2012 | Active | |
| Calchan Holdings Limited Director • Investor | 3 Oct 2011←11 Months→31 Aug 2012 | Dissolved | |
| OLD Convergence Pharmaceuticals Limited Director • Investor | 4 Oct 2010←1 Year 11 Months→31 Aug 2012 | Active | |
Mutual People
- Olswang Cosec LimitedNightstarx Limited, Spur Therapeutics Limited, Convergence Pharmaceuticals Holdings Limited, and 2 more are mutual companies.
- Olswang Directors 1 LimitedCalchan Holdings Limited, Convergence Pharmaceuticals Holdings Limited, Nightstarx Limited, and 2 more are mutual companies.
- Olswang Directors 2 LimitedConvergence Pharmaceuticals Holdings Limited, OLD Convergence Pharmaceuticals Limited, Calchan Holdings Limited, and 2 more are mutual companies.
- Mr Christopher Alan MackieOLD Convergence Pharmaceuticals Limited, Calchan Holdings Limited, Spur Therapeutics Limited, and 2 more are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
